Provided by Tiger Trade Technology Pte. Ltd.

Sagimet Biosciences Inc.

5.32
+0.08001.53%
Post-market: 5.320.00000.00%18:49 EDT
Volume:160.02K
Turnover:837.54K
Market Cap:173.01M
PE:-3.37
High:5.33
Open:5.12
Low:5.10
Close:5.24
52wk High:11.41
52wk Low:1.73
Shares:32.52M
Float Shares:22.63M
Volume Ratio:0.32
T/O Rate:0.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5800
EPS(LYR):-1.5800
ROE:-38.20%
ROA:-25.70%
PB:1.55
PE(LYR):-3.37

Loading ...

Apr 30, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 12, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 12, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Feb 14, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 23, 2024

Correspondence

Form CORRESP - Correspondence
Aug 16, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Jul 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities